Skip to main content
HBIO logo
HBIO
(NASDAQ)
Harvard Bioscience, Inc.
$5.20-- (--)
Loading... - Market loading

Harvard Bioscience (HBIO) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

Harvard Bioscience Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Harvard Bioscience, Inc. (HBIO) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents8.614.114.284.517.828.328.348.175.73
Cash & Short-Term Investments8.614.114.284.517.828.328.348.175.73
Accounts Receivable16.0414.8716.1016.7121.8317.7720.7021.4617.09
Inventory20.8123.2524.7226.4427.5922.2622.0625.0921.35
Other Current Assets2.762.903.943.474.343.362.473.1112.11
Total Current Assets48.2345.1249.0451.1261.5851.7053.5754.7247.54
Non-Current Assets
Property, Plant & Equipment (Net)11.9611.248.759.1810.3111.7213.245.904.14
Long-Term Investments0.000.003.500.000.000.000.00-0.210.00
Goodwill9.5656.3257.0756.2657.6958.5957.3857.3039.97
Intangible Assets7.6411.1316.0421.0127.3933.1538.4145.7617.20
Other Non-Current Assets2.692.832.977.455.381.092.274.920.32
Total Non-Current Assets31.8581.5388.3394.24100.76104.55111.30113.3561.82
Total Assets80.07126.64137.37145.36162.34156.25164.87168.07109.35
Current Liabilities
Accounts Payable3.654.795.556.454.915.975.347.364.41
Short-Term Debt0.0038.117.283.815.383.839.322.002.77
Current Portion of Long-Term Debt0.0036.965.863.813.241.720.000.000.00
Accrued Liabilities0.002.264.433.876.534.150.000.000.00
Deferred Revenue3.453.810.003.374.273.773.954.190.63
Other Current Liabilities11.528.2513.713.6210.547.196.096.936.48
Total Current Liabilities21.9654.9626.5423.2525.3221.0525.3121.5114.04
Non-Current Liabilities
Long-Term Debt35.876.3835.5043.0151.5853.7755.1458.808.98
Deferred Tax Liabilities0.320.710.780.591.561.901.972.303.96
Other Non-Current Liabilities1.311.261.481.010.492.850.753.295.43
Total Non-Current Liabilities44.388.3537.7549.8953.6358.5257.8664.3814.41
Total Liabilities66.3463.3064.2973.1478.9479.5783.1885.8928.45
Stockholders' Equity
Common Stock0.450.440.430.450.450.440.440.440.42
Retained Earnings-214.71-158.01-145.61-142.19-132.67-132.39-124.58-119.89-116.97
Accumulated Other Comprehensive Income-11.67-15.67-14.19-15.05-10.03-13.07-12.69-13.53-10.68
Additional Paid-in Capital239.67236.58232.44229.01225.65221.69218.52215.71208.12
Shares Outstanding44.7244.0743.3942.0841.140.000.000.000.00
Total Stockholders' Equity13.7363.3473.0772.2283.4076.6881.6982.1880.90
Total Liabilities & Equity80.07126.64137.37145.36162.34156.25164.87168.07109.35

Frequently Asked Questions About Harvard Bioscience Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is HBIO's debt level?

Review Harvard Bioscience's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.